Johnson & Johnson to pay $572 million over opioid crisis, Brazil rejects G7 aid for the Amazon, and more top news
LinkedIn Daily Rundown (US)
The professional news you need to know now.
The news professionals are talking about now, curated by LinkedIn’s editors. Join the conversation on today's stories in the comments.
Johnson & Johnson will pay $572 million for its role in the opioid-addiction crisis in Oklahoma, a state judge ruled Monday in the first case brought to trial over the epidemic. The verdict suggests other drug companies may be found liable as thousands of similar cases are brought by states and cities against big pharmaceutical companies. Purdue and Teva settled out of court for $270 million and $85 million, respectively. Over 6,000 Oklahomans died of opioid overdoses since 2000. J&J said it would appeal. ? Here’s what people are saying.
Brazil's government says it will turn down a roughly $20 million offer of aid to combat fires in the Amazon rainforest. G7 leaders had committed to help battle fires and launch an initiative to protect the forest on Monday at their summit in Biarritz, France. President Bolsonaro said the offer would leave his country like "a colony or no man's land." The country's National Space Research Institute recorded 76,720 wildfires in the forest this year — up 85% since 2018. ? Here’s what people are saying.
The first patient has died from a lung illness linked to vaping, and almost 200 cases of respiratory illnesses tied to the activity have been reported this summer, according to government officials. The Centers for Disease Control and Prevention says it’s unclear if the illnesses occurred as a result of the e-cigarette devices, the ingredients or other “contaminants.” Vaping has been promoted as a way to cut back on smoking, but its marketing practices and the lack of long-term studies on its health effects are drawing scrutiny. ? Here’s what people are saying.
The shock retirement of 29-year-old NFL quarterback Andrew Luck has highlighted a growing number of professional footballers exiting in their prime over worries about their long-term health. Football and bodily harm “remain inseparable,” The Atlantic writes. Luck, who leaves $50 million from his contract behind, represents an emerging awareness of football’s long-term toll as players contemplate not only their current earnings, but their physical and mental health. ? Here’s what people are saying.
Colonel Sanders is taking a bite out of the meatless-meat craze with vegan fried chicken. KFC will start testing a plant-based fried chicken alternative from Beyond Meat at an Atlanta location Tuesday. KFC has beat competitors Popeyes and Chick-fil-A in introducing a meatless chicken product to the U.S., reports CNBC. The company said it will consider customer feedback before deciding on next steps. ? Here’s what people are saying.
Idea of the Day: Now is the time for business leaders to step up, says Gary Shapiro, President and CEO at Consumer Technology Association.
“Whether it is decent wages, skills training or environmental protection, companies and industries can make a difference.”
What's your take on today’s stories? Share your thoughts in the comments.
The Daily Rundown is now on Alexa! To listen to the professional news trending on LinkedIn, ask, "Alexa, what's the latest from LinkedIn?" or add LinkedIn to your Flash Briefing.
Directional Driller @ Hendry Management Consultants Inc
5 年I don’t agree with these lawsuits. They make the drugs only. They don’t force anyone to take them nor do they prescribe them. If this is the new norm then beer companies and auto makers will be out of business.
| ??????| ??x???| ???? ???? ????????????????|??????????????| ???????? ????????| ???????????? ????????????.?? |??????????
5 年They cause cancer and target children this is sick and upsetting Linked In I wonder who your sponsors are ????????????????
Faculty teaching ADNs Obstetrics at Daytona College
5 年Do not mess up because the pain center will drop you.
Retired Reinsurance Corporate Finance Consultant at Auto Club Group AAA Michigan
5 年About time
Application Engineer at Chart Industries
5 年I am in total disagreement. The manufacturer is not culpable for misuse and abuse of it's products. This is a judicial decision totally directed by the popular opinion and not investigation. Insurance companies refusal to cover cost for alternative pain treatments opened the door for doctors to over-prescribe in an attempt to ease the suffering of their patients. We have also determined that the abuser has no choice in the misuse of their medication (if they are even prescribed the meds). Use of opioid medication is the only relief that suffers of real chronic (excruciating) pain may find and demonizing the companies that provide this relief is ridiculous. In my experience use of the prescribed amount and as needed to relieve pain symptoms has not produced any resistance to the medications effectiveness and I can only determine that people cycling into perpetual abuse and overdose are doing so with their eyes open and like most drug addicts choosing to take more than needed medication for the side effects not to treat their condition.